← Leaderboards
Steven M Larson
Sloan-Kettering Institute For Cancer Res
$7,955,537
Attributed
$10,302,000
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$30,402,218 · 14
By mechanism
P50$22,209,018 · 7
R01$3,519,694 · 1
P01$2,920,275 · 3
S10$998,000 · 2
R21$755,231 · 1
Top collaborators
- Ronald G Blasberg5 shared
- John L Humm5 shared
- Robert Michael Tuttle5 shared
Most similar at Sloan-Kettering Institute For Cancer Res
Same institution · by research overlap
- Pier Paolo Pandolfi$54,825,346
- Jason A Koutcher$20,695,436
- Glenn Heller$7,155,475
- William L Gerald$10,319,111
- Neal Rosen$21,048,001
Research focus
Positron-Emission TomographyImageBaseMolecular ImagingIn VivoMemorial Sloan-Kettering Cancer CenterMalignant NeoplasmsRadiotracerPharmaceutical PreparationsTumorInhibitor/AntagonistAnimalsResearch Project GrantsTracerGlycolysisLesionUptakeResponseMolecularAndrogen ReceptorCancer PatientClinical TrialsBioimaging /Biomedical ImagingMalignant Neoplasm Of Thyroid
Grant awards (55)
124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer$723,362
R01 · FY2020 · CA · contact PI
124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer$706,749
R01 · FY2019 · CA · contact PI
124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer$695,342
R01 · FY2018 · CA · contact PI
124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer$695,342
R01 · FY2017 · CA · contact PI
124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer$698,899
R01 · FY2016 · CA · contact PI
MSKCC Center for Molecular Imaging in Cancer$1,471,710
P50 · FY2015 · CA · contact PI
Imaging the Effects of Inhibition of Oncogene Signaling on Tumor Growth and Metabolism$256,076
P50 · FY2015 · CA · contact PI
Refining Antiandrogen Therapy for Positron Emission Tomography$244,603
P50 · FY2015 · CA · contact PI
Organization and Administration$73,885
P50 · FY2015 · CA · contact PI
MSKCC Center for Molecular Imaging in Cancer$1,455,670
P50 · FY2014 · CA · contact PI
Imaging the Effects of Inhibition of Oncogene Signaling on Tumor Growth and....$228,873
P50 · FY2014 · CA · contact PI
Refining Antiandrogen Therapy for Positron Emission Tomography$225,552
P50 · FY2014 · CA · contact PI
Organization and Administration$47,293
P50 · FY2014 · CA · contact PI
MSKCC Center for Molecular Imaging in Cancer$1,524,418
P50 · FY2013 · CA · contact PI
Imaging the Effects of Inhibition of Oncogene Signaling on Tumor Growth and....$237,286
P50 · FY2013 · CA · contact PI
Refining Antiandrogen Therapy for Positron Emission Tomography$234,969
P50 · FY2013 · CA · contact PI
Statistics$49,565
P50 · FY2013 · CA · contact PI
MSKCC Center for Molecular Imaging in Cancer$1,431,511
P50 · FY2012 · CA · contact PI
124I-cG250 ImmunoPET Imaging of Sunitinib Treatment Response in Renal Cell Cancer$379,518
R21 · FY2012 · CA · contact PI
Imaging Core$323,994
P01 · FY2012 · CA · contact PI
Imaging the Effects of Inhibition of Oncogene Signaling on Tumor Growth and....$222,094
P50 · FY2012 · CA · contact PI
Refining Antiandrogen Therapy for Positron Emission Tomography$221,002
P50 · FY2012 · CA · contact PI
Statistics$46,905
P50 · FY2012 · CA · contact PI
MSKCC Center for Molecular Imaging in Cancer$1,580,501
P50 · FY2011 · CA · contact PI
124I-cG250 ImmunoPET Imaging of Sunitinib Treatment Response in Renal Cell Cancer$375,713
R21 · FY2011 · CA · contact PI
Imaging Core$325,805
P01 · FY2011 · CA · contact PI
MSKCC Center for Molecular Imaging in Cancer$1,904,290
P50 · FY2010 · CA · contact PI
Imaging Core$335,884
P01 · FY2010 · CA · contact PI
Molecular Imaging of Castrate- Resistance Metastatic Prostate Cancer$203,991
P50 · FY2010 · CA · contact PI
MSKCC Center for Molecular Imaging in Cancer$1,904,290
P50 · FY2009 · CA · contact PI
Imaging Core$329,294
P01 · FY2009 · CA · contact PI
Biophysics and Nuclear Medicine$267,568
P01 · FY2009 · CA · contact PI
Molecular Imaging of Castrate- Resistance Metastatic Prostate Cancer$203,991
P50 · FY2009 · CA · contact PI
MSKCC Center for Molecular Imaging in Cancer$1,904,290
P50 · FY2008 · CA · contact PI
Imaging Core$320,044
P01 · FY2008 · CA · contact PI
Biophysics and Nuclear Medicine$142,265
P01 · FY2008 · CA · contact PI
Molecular Imaging of Castrate- Resistance Metastatic Prostate Cancer$111,715
P50 · FY2008 · CA · contact PI
MSKCC CENTER FOR IN VIVO MOLECULAR IMAGING IN CANCER$1,848,429
P50 · FY2005 · CA
SHARED INSTRUMENT: FOCUS MICROPET: CANCER$499,000
S10 · FY2005 · RR
Shared Instrument: Focus microPET$499,000
S10 · FY2005 · RR
MSKCC CENTER FOR IN VIVO MOLECULAR IMAGING IN CANCER$2,534,953
P50 · FY2004 · CA
MSKCC CENTER FOR IN VIVO MOLECULAR IMAGING IN CANCER$41,156
P50 · FY2004 · CA
MSKCC CENTER FOR IN VIVO MOLECULAR IMAGING IN CANCER$2,000,000
P50 · FY2003 · CA
CORE--BIOPHYSICS AND NUCLEAR MEDICINE$291,807
P01 · FY2002 · CA
Imaging markers of progression &response in prostate cancer$0
P50 · FY2002 · CA
Imaging markers of progression &response in prostate cancer$0
P50 · FY2002 · CA
Core--Imaging$0
P01 · FY2002 · CA
Core--PET/gamma imaging$0
P50 · FY2002 · CA
Core--PET/gamma imaging$0
P50 · FY2002 · CA
CORE--BIOPHYSICS AND NUCLEAR MEDICINE$291,807
P01 · FY2001 · CA
Core--PET/gamma imaging$0
P50 · FY2001 · CA
Imaging markers of progression &response in prostate cancer$0
P50 · FY2001 · CA
CORE--BIOPHYSICS AND NUCLEAR MEDICINE$291,807
P01 · FY2000 · CA
Core--PET/gamma imaging$0
P50 · FY2000 · CA
Imaging markers of progression &response in prostate cancer$0
P50 · FY2000 · CA